Outsiders take advantage of a Los Angeles program aimed to aid communities hit hard by COVID-19; Biden plans to send 25 million masks out to Americans; real-world data highlight the efficacy of the Pfizer/BioNTech COVID-19 vaccine.
A program intended to improve access to COVID-19 vaccines among hard-hit communities of color in California is being misused by outsiders, The Los Angeles Times reported. The program relies on special access codes that enable people to make appointments on a vaccine scheduling website. However, the codes that were provided to community organizations to distribute to people in largely Black and Latino communities are now being circulated among wealthier Los Angeles residents working from home who are not yet eligible for vaccines. Codes were intended for use by people in communities of color who are healthcare workers and those older than 65 who may struggle to get an appointment.
In a push for equity, the Biden administration announced it plans to distribute more than 25 million American-made cloth masks to communities hit hard by COVID-19, according to the Associated Press. The effort will begin next month and will distribute masks through Federally Qualified Health Centers and the nation’s food bank supply and food pantry system. The masks, made in both adult and kid sizes, are estimated to reach 12 million to 15 million Americans. The administration noted it will not be distributing N95 masks, but the ones it will send adhere to CDC guidelines. In the early days of his presidency, President Biden urged all Americans to wear face masks for the first 100 days of his term and required masking in all federal buildings and on public transportation.
Data from an independently reviewed real-world study show that 2 doses of the Pfizer/BioNTech vaccine cut symptomatic COVID-19 cases by 94% across all age groups, while a single shot was 57% effective in protecting against symptomatic infections after 2 weeks, Reuters reported. Evidence was reported from Israel, which is 2 months into one of the world’s fastest vaccine rollouts, and is based on data from 1.2 million vaccinated individuals. Results also show the vaccine is effective against a highly transmissible variant first detected in the United Kingdom, which was the dominant version of the virus in Israel at the time of the study. Findings were published and peer-reviewed in the New England Journal of Medicine.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
The Federal Trade Commission (FTC) issued letters to 10 companies to warn them that certain drug patents were improperly listed; the US Department of Agriculture (USDA) will begin testing ground beef for bird flu particles; rural Americans are more likely to die early from 1 of the 5 leading causes of death than those who live in urban areas.
Read More